Co-Authors
This is a "connection" page, showing publications co-authored by Laura Andreoli and Mirko Scarsi.
Connection Strength
1.796
-
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Ann Rheum Dis. 2020 10; 79(10):1286-1289.
Score: 0.895
-
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada. Ann Rheum Dis. 2021 Jan 27.
Score: 0.232
-
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al. Ann Rheum Dis. 2020 Aug 27.
Score: 0.225
-
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease. Rheumatology (Oxford). 2020 07 01; 59(7):1769-1770.
Score: 0.223
-
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Clin Rheumatol. 2020 08; 39(8):2489-2490.
Score: 0.222